Showing results (1931-1940 of 2,249) with videos related to
Sort By:
Pageof 225
Scientific Reports|December 21, 2023
Clinical characterisation of women with persistent genital arousal disorder: the iPGAD-studyFranziska M L M Kümpers, Christopher Sinke, Cordula Schippert, et al.Frontiers in Behavioral Neuroscience|July 21, 2017
Lack of Associations between Female Hormone Levels and Visuospatial Working Memory, Divided Attention and Cognitive Bias across Two Consecutive Menstrual CyclesBrigitte Leeners, Tillmann H C Kruger, Kirsten Geraedts, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Biochemical tests in the diagnosis of childhood growth hormone deficiencyV Tillmann, J M Buckler, M S Kibirige, et al.Transplantation|December 10, 1999
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trialH Wedemeyer, K H Böker, K Pethig, et al.Biology|January 21, 2023
Evaluation of Epigenetic Age Acceleration Scores and Their Associations with CVD-Related Phenotypes in a Population CohortOlga Chervova, Elizabeth Chernysheva, Kseniia Panteleeva, et al.Journal of Proteome Research|May 28, 2009
Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a microbalance array and mass spectrometry (MAMS)Thomas M A Gronewold, Antje Baumgartner, Jessica Hierer, et al.Elife|September 3, 2021
Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceuticalElisabeth Gludovacz, Kornelia Schuetzenberger, Marlene Resch, et al.The Journal of Chemical Physics|June 20, 2023
Photoelectron spectroscopy from a liquid flatjetDominik Stemer, Tillmann Buttersack, Henrik Haak, et al.Glycobiology|September 28, 2020
Human diamine oxidase cellular binding and internalization in vitro and rapid clearance in vivo are not mediated by N-glycans but by heparan sulfate proteoglycan interactionsElisabeth Gludovacz, Kornelia Schuetzenberger, Marlene Resch, et al.Journal of Hepatology|February 24, 2007
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrationJens Rosenau, Therese Kreutz, Matthias Kujawa, et al.Pageof 225